CervoMed Inc. – NASDAQ:CRVO

CervoMed stock price today

$9.21
+6.81
+283.75%
Financial Health
0
1
2
3
4
5
6
7
8
9

CervoMed stock price monthly change

-84.95%
month

CervoMed stock price quarterly change

-84.95%
quarter

CervoMed stock price yearly change

-63.25%
year

CervoMed key metrics

Market Cap
18.15M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
N/A
Revenue
N/A
EBITDA
N/A
Income
N/A
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

CervoMed stock price history

CervoMed stock forecast

CervoMed financial statements

CervoMed Inc. (NASDAQ:CRVO): Profit margin
2015 0 -6.71M
2017 0 -1.36M
2020 0 -14.18M
2023 7.14M -2.17M -30.4%
CervoMed Inc. (NASDAQ:CRVO): Debt to assets
2014 42778751 4.61M 10.78%
2015 2276596 2.31M 101.83%
2017 26145815 4.91M 18.8%
2023 9972521 2.59M 26.03%
CervoMed Inc. (NASDAQ:CRVO): Cash Flow
2017 -12.33M -447.82K 20.12M
2019 -9.85M 0 16.04M
2022 -2.57M -12.23M 0
2023 -7.44M 0 11.14M

CervoMed alternative data

CervoMed Inc. (NASDAQ:CRVO): Employee count
Dec 2023 4
Jan 2024 4
Feb 2024 4
Mar 2024 4
Apr 2024 4
May 2024 4
Jun 2024 8
Jul 2024 8
Dec 2024 8

CervoMed other data

CervoMed Inc. (NASDAQ:CRVO): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 36
Transaction Date Insider Security Shares Price per share Total value Source
Sale
BOGER JOSHUA S director, 10 percent owner:
Common Stock 36 N/A N/A
Thursday, 12 December 2024
globenewswire.com
Tuesday, 10 December 2024
benzinga.com
marketwatch.com
reuters.com
globenewswire.com
Wednesday, 27 November 2024
globenewswire.com
Tuesday, 12 November 2024
globenewswire.com
Friday, 8 November 2024
globenewswire.com
Thursday, 7 November 2024
globenewswire.com
Monday, 4 November 2024
globenewswire.com
Tuesday, 29 October 2024
globenewswire.com
Wednesday, 2 October 2024
globenewswire.com
Friday, 20 September 2024
zacks.com
Tuesday, 27 August 2024
globenewswire.com
Thursday, 22 August 2024
globenewswire.com
Tuesday, 30 July 2024
globenewswire.com
Wednesday, 17 July 2024
globenewswire.com
Thursday, 11 July 2024
globenewswire.com
Friday, 28 June 2024
investorplace.com
Tuesday, 11 June 2024
globenewswire.com
Monday, 20 May 2024
http://feeds.benzinga.com
globenewswire.com
Wednesday, 15 May 2024
globenewswire.com
Tuesday, 2 April 2024
Seeking Alpha
Thursday, 28 March 2024
GlobeNewsWire
  • What's the price of CervoMed stock today?

    One share of CervoMed stock can currently be purchased for approximately $9.21.

  • When is CervoMed's next earnings date?

    Unfortunately, CervoMed's (CRVO) next earnings date is currently unknown.

  • Does CervoMed pay dividends?

    No, CervoMed does not pay dividends.

  • How much money does CervoMed make?

    CervoMed has a market capitalization of 18.15M.

  • What is CervoMed's stock symbol?

    CervoMed Inc. is traded on the NASDAQ under the ticker symbol "CRVO".

  • What is CervoMed's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of CervoMed?

    Shares of CervoMed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does CervoMed have?

    As Dec 2024, CervoMed employs 8 workers, which is 100% more then previous quarter.

  • When CervoMed went public?

    CervoMed Inc. is publicly traded company for more then 17 years since IPO on 23 May 2008.

  • What is CervoMed's official website?

    The official website for CervoMed is cervomed.com.

  • Where are CervoMed's headquarters?

    CervoMed is headquartered at 20 Park Plaza, Boston, MA.

  • How can i contact CervoMed?

    CervoMed's mailing address is 20 Park Plaza, Boston, MA and company can be reached via phone at +61 77444400.

CervoMed company profile:

CervoMed Inc.

cervomed.com
Exchange:

NASDAQ

Full time employees:

8

Industry:

Biotechnology

Sector:

Healthcare

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

20 Park Plaza
Boston, MA 02116

CIK: 0001053691
ISIN: US15713L1098
: